Young, J.L.; Miller, R.W.Incidence of malignant tumors in U.S. children. J Pediatr86(2):254-258, February, 1975.
2.
Breslow, N.; McCann, B.Statistical estimation of prognosis for children with neuroblastoma . Cancer Res31:2098-2103 December, 1971.
3.
August, C.S. ; et al. Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogenic or autologous marrow reconstitution. J Clin Onc2(6):609-615, June, 1984.
4.
Hayes, F.A.; et al. Surgicopathologic staging of neuroblastoma: Prognostic significance of regional lymph node metastasis. J Pediatr102(1):59-62, January, 1983.
5.
Evans, A.E.; D'Angio, G.J.; Randolph, J.A. A proposed staging for children with neuroblastoma. Children's Cancer Study Group A. Cancer27(2):374-378, February, 1971.
6.
Jaffe, N.Neuroblastoma: Review of the literature and an examination of factors contributing to its enigmatic character. Ca Treat Rev3(2):61-82, January, 1976.
7.
Laug, W.E.; et al. Initial urinary catecholamine metabolites and prognosis in neuroblastoma . Pediatrics62(1):77-87, July, 1978.
8.
Hann, H.-W.L. ; Levy, H.M.; Evans , A.E.Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res40:1411-1413, May, 1980.
9.
Zeltzer, P.M. ; et al. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet2:361-363, August 13, 1983.
10.
Shimada, H. ; et al. Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. JNCI73(2):405-416, August, 1984.
11.
Seeger, R.C. ; et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med313(18):1111-1116, October 31, 1985.
